Premium
Letter: promising results of Helicobacter pylori eradication with vonoprazan‐based triple therapy after failure of proton pump inhibitor‐based triple therapy
Author(s) -
Inaba T.,
Iwamuro M.,
Toyokawa T.,
Okada H.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13462
Subject(s) - rabeprazole , medicine , esomeprazole , clarithromycin , helicobacter pylori , amoxicillin , proton pump inhibitor , gastroenterology , cyp2c19 , discontinuation , adverse effect , omeprazole , pharmacology , antibiotics , microbiology and biotechnology , cytochrome p450 , metabolism , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom